$268 Million is the total value of Altium Capital Management LP's 95 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| OCUP | New | OCUPHIRE PHARMA INC | $13,425,000 | – | 2,068,530 | +100.0% | 5.01% | – |
| CRIS | New | CURIS INC | $6,732,000 | – | 822,009 | +100.0% | 2.51% | – |
| OCUL | New | OCULAR THERAPEUTIX INC | $6,276,000 | – | 303,174 | +100.0% | 2.34% | – |
| ISEE | New | IVERIC BIO INC | $6,237,000 | – | 902,633 | +100.0% | 2.33% | – |
| STRO | New | SUTRO BIOPHARMA INC | $6,008,000 | – | 276,719 | +100.0% | 2.24% | – |
| SNDX | New | SYNDAX PHARMACEUTICALS INC | $5,862,000 | – | 263,596 | +100.0% | 2.19% | – |
| GNPX | New | GENPREX INC | $5,851,000 | – | 1,409,785 | +100.0% | 2.18% | – |
| VSTM | New | VERASTEM INC | $5,819,000 | – | 2,731,974 | +100.0% | 2.17% | – |
| ANAB | New | ANAPTYSBIO INC | $5,616,000 | – | 261,209 | +100.0% | 2.10% | – |
| BLU | New | BELLUS HEALTH INC NEW | $5,149,000 | – | 1,682,535 | +100.0% | 1.92% | – |
| CRNX | New | CRINETICS PHARMACEUTICALS IN | $5,107,000 | – | 361,930 | +100.0% | 1.91% | – |
| INSM | New | INSMED INC | $4,952,000 | – | 148,743 | +100.0% | 1.85% | – |
| ITCI | New | INTRA CELLULAR THERAPIES INC | $4,876,000 | – | 153,348 | +100.0% | 1.82% | – |
| COGT | New | COGENT BIOSCIENCES INC | $4,858,000 | – | 432,563 | +100.0% | 1.81% | – |
| IMTX | New | IMMATICS N.V. | $4,377,000 | – | 405,670 | +100.0% | 1.63% | – |
| ARYA | New | ARYA SCIENCES ACQUISITION CO | $4,340,000 | – | 400,000 | +100.0% | 1.62% | – |
| MYGN | New | MYRIAD GENETICS INC | $4,324,000 | – | 218,650 | +100.0% | 1.61% | – |
| EUCRU | New | EUCRATES BIOMEDICAL ACQU CORunit 10/23/2027 | $4,264,000 | – | 400,000 | +100.0% | 1.59% | – |
| CLDX | New | CELLDEX THERAPEUTICS INC NEW | $4,196,000 | – | 239,520 | +100.0% | 1.57% | – |
| CSTL | New | CASTLE BIOSCIENCES INC | $4,163,000 | – | 61,991 | +100.0% | 1.55% | – |
| ILMN | New | ILLUMINA INC | $4,144,000 | – | 11,200 | +100.0% | 1.55% | – |
| PODD | New | INSULET CORP | $4,141,000 | – | 16,200 | +100.0% | 1.55% | – |
| AUPH | New | AURINIA PHARMACEUTICALS INC | $4,065,000 | – | 293,917 | +100.0% | 1.52% | – |
| CHAQ | New | CHARDAN HEALTHCR ACQSTN 2 CO | $3,966,000 | – | 388,845 | +100.0% | 1.48% | – |
| CNST | New | CONSTELLATION PHARMCETICLS I | $3,866,000 | – | 134,233 | +100.0% | 1.44% | – |
| CHRS | New | COHERUS BIOSCIENCES INC | $3,770,000 | – | 216,925 | +100.0% | 1.41% | – |
| PTGX | New | PROTAGONIST THERAPEUTICS INC | $3,747,000 | – | 185,854 | +100.0% | 1.40% | – |
| IMUX | New | IMMUNIC INC | $3,733,000 | – | 244,155 | +100.0% | 1.39% | – |
| IMVT | New | IMMUNOVANT INC | $3,585,000 | – | 77,622 | +100.0% | 1.34% | – |
| LNTH | New | LANTHEUS HLDGS INC | $3,541,000 | – | 262,465 | +100.0% | 1.32% | – |
| CRDF | New | CARDIFF ONCOLOGY INC | $3,338,000 | – | 185,552 | +100.0% | 1.25% | – |
| KDNY | New | CHINOOK THERAPEUTICS INC | $3,264,000 | – | 205,799 | +100.0% | 1.22% | – |
| MICT | New | MICT INC | $3,190,000 | – | 1,533,425 | +100.0% | 1.19% | – |
| VINC | New | VINCERA PHARMA INC | $3,140,000 | – | 150,150 | +100.0% | 1.17% | – |
| AVDL | New | AVADEL PHARMACEUTICALS PLCsponsored adr | $3,110,000 | – | 465,589 | +100.0% | 1.16% | – |
| HAE | New | HAEMONETICS CORP | $3,105,000 | – | 26,144 | +100.0% | 1.16% | – |
| SCYX | New | SCYNEXIS INC | $3,060,000 | – | 400,000 | +100.0% | 1.14% | – |
| OEG | New | ORBITAL ENERGY GROUP INC | $2,965,000 | – | 1,353,995 | +100.0% | 1.11% | – |
| SIEN | New | SIENTRA INC | $2,928,000 | – | 752,634 | +100.0% | 1.09% | – |
| AHACU | New | ALPHA HEALTHCARE ACQUISTN COunit 09/21/2027 | $2,907,000 | – | 275,000 | +100.0% | 1.08% | – |
| HLXA | New | HELIX ACQUISITION CORP | $2,843,000 | – | 250,000 | +100.0% | 1.06% | – |
| NNDM | New | NANO DIMENSION LTDsponsord ads new | $2,772,000 | – | 304,600 | +100.0% | 1.04% | – |
| LSAQ | New | LIFESCI ACQUISITION II CORP | $2,668,000 | – | 250,000 | +100.0% | 1.00% | – |
| CHFWU | New | CONSONANCE HFW ACQUISITION Cunit 99/99/9999 | $2,618,000 | – | 250,000 | +100.0% | 0.98% | – |
| TMPMU | New | TURMERIC ACQUISITION CORPunit 10/08/2025 | $2,609,000 | – | 254,000 | +100.0% | 0.97% | – |
| FSDC | New | FS DEV CORP | $2,574,000 | – | 234,000 | +100.0% | 0.96% | – |
| EIGR | New | EIGER BIOPHARMACEUTICALS INC | $2,427,000 | – | 197,500 | +100.0% | 0.91% | – |
| SRSAU | New | SARISSA CAPITAL ACQUISITN COunit 10/23/2027 | $2,396,000 | – | 225,000 | +100.0% | 0.89% | – |
| CMLFU | New | CM LIFE SCIENCES INCunit 09/01/2025 | $2,320,000 | – | 200,000 | +100.0% | 0.87% | – |
| TCRR | New | TCR2 THERAPEUTICS INC | $2,289,000 | – | 73,991 | +100.0% | 0.86% | – |
| XENT | New | INTERSECT ENT INC | $2,282,000 | – | 99,661 | +100.0% | 0.85% | – |
| TLSA | New | TIZIANA LIFE SCIENCES PLCsponsored ads | $2,177,000 | – | 1,077,883 | +100.0% | 0.81% | – |
| AGLE | New | AEGLEA BIOTHERAPEUTICS INC | $2,107,000 | – | 267,753 | +100.0% | 0.79% | – |
| EPIX | New | ESSA PHARMA INC | $2,089,000 | – | 175,067 | +100.0% | 0.78% | – |
| TVTX | New | TRAVERE THERAPEUTICS INC | $2,085,000 | – | 76,484 | +100.0% | 0.78% | – |
| KPTI | New | KARYOPHARM THERAPEUTICS INC | $2,074,000 | – | 133,951 | +100.0% | 0.77% | – |
| JYAC | New | JIYA ACQUISITION CORP | $2,060,000 | – | 200,000 | +100.0% | 0.77% | – |
| GMED | New | GLOBUS MED INCcl a | $2,055,000 | – | 31,512 | +100.0% | 0.77% | – |
| DXCM | New | DEXCOM INC | $2,033,000 | – | 5,500 | +100.0% | 0.76% | – |
| ONCT | New | ONCTERNAL THERAPEUTICS INC | $2,017,000 | – | 411,667 | +100.0% | 0.75% | – |
| RIGL | New | RIGEL PHARMACEUTICALS INC | $1,999,000 | – | 571,026 | +100.0% | 0.75% | – |
| LRMR | New | LARIMAR THERAPEUTICS INC | $1,997,000 | – | 93,261 | +100.0% | 0.75% | – |
| ICUI | New | ICU MED INC | $1,999,000 | – | 9,321 | +100.0% | 0.75% | – |
| CBIO | New | CATALYST BIOSCIENCES INC | $1,980,000 | – | 313,745 | +100.0% | 0.74% | – |
| OTIC | New | OTONOMY INC | $1,940,000 | – | 299,890 | +100.0% | 0.72% | – |
| OPTN | New | OPTINOSE INC | $1,899,000 | – | 458,589 | +100.0% | 0.71% | – |
| CTIC | New | CTI BIOPHARMA CORP | $1,897,000 | – | 588,992 | +100.0% | 0.71% | – |
| BCRX | New | BIOCRYST PHARMACEUTICALS INC | $1,863,000 | – | 250,000 | +100.0% | 0.70% | – |
| OPENW | New | OPENDOOR TECHNOLOGIES INC*w exp 12/18/202 | $1,853,000 | – | 240,000 | +100.0% | 0.69% | – |
| CTMX | New | CYTOMX THERAPEUTICS INC | $1,793,000 | – | 273,703 | +100.0% | 0.67% | – |
| CLRB | New | CELLECTAR BIOSCIENCES INC | $1,772,000 | – | 851,852 | +100.0% | 0.66% | – |
| ARQT | New | ARCUTIS BIOTHERAPEUTICS INC | $1,771,000 | – | 62,962 | +100.0% | 0.66% | – |
| HARP | New | HARPOON THERAPEUTICS INC | $1,694,000 | – | 101,994 | +100.0% | 0.63% | – |
| SBEWS | New | SWITCHBACK ENERGY ACQUISTN C*w exp 07/25/202 | $1,619,000 | – | 105,000 | +100.0% | 0.60% | – |
| EPZM | New | EPIZYME INC | $1,412,000 | – | 130,000 | +100.0% | 0.53% | – |
| BCTG | New | BCTG ACQUISITION CORP | $1,373,000 | – | 120,000 | +100.0% | 0.51% | – |
| LIFE | New | ATYR PHARMA INC | $1,289,000 | – | 332,258 | +100.0% | 0.48% | – |
| VRCA | New | VERRICA PHARMACEUTICALS INC | $1,252,000 | – | 108,794 | +100.0% | 0.47% | – |
| BLSA | New | BCLS ACQUISITION CORP | $1,114,000 | – | 100,000 | +100.0% | 0.42% | – |
| NMTR | New | 9 METERS BIOPHARMA INC | $1,087,000 | – | 1,264,994 | +100.0% | 0.41% | – |
| ROCCU | New | ROTH CH ACQUISITION II COunit 12/11/2025 | $1,040,000 | – | 100,000 | +100.0% | 0.39% | – |
| CNSP | New | CNS PHARMACEUTICALS INC | $951,000 | – | 534,148 | +100.0% | 0.36% | – |
| FATBW | New | FAT BRANDS INC*w exp 06/30/202 | $810,000 | – | 300,000 | +100.0% | 0.30% | – |
| VINCW | New | VINCERA PHARMA INC*w exp 12/24/202 | $710,000 | – | 215,250 | +100.0% | 0.26% | – |
| CHAQWS | New | CHARDAN HEALTHCR ACQSTN 2 CO*w exp 03/05/202 | $495,000 | – | 500,000 | +100.0% | 0.18% | – |
| CEREW | New | CEREVEL THERAPEUTICS HLDNG I*w exp 06/09/202 | $365,000 | – | 64,666 | +100.0% | 0.14% | – |
| IMTXW | New | IMMATICS N.V.*w exp 07/01/202 | $281,000 | – | 97,467 | +100.0% | 0.10% | – |
| KBNT | New | KUBIENT INC | $236,000 | – | 42,269 | +100.0% | 0.09% | – |
| AMHCW | New | AMPLITUDE HLTHCRE AQUSTIN CO*w exp 12/01/202 | $236,000 | – | 162,500 | +100.0% | 0.09% | – |
| GLEOWS | New | GALILEO ACQUISITION CORP*w exp 10/31/202 | $168,000 | – | 200,000 | +100.0% | 0.06% | – |
| VERO | New | VENUS CONCEPT INC | $162,000 | – | 93,643 | +100.0% | 0.06% | – |
| QTNT | New | QUOTIENT LTD | $130,000 | – | 24,912 | +100.0% | 0.05% | – |
| HSAQ | New | HEALTH SCIENCES ACQ CORP 2 | $128,000 | – | 10,000 | +100.0% | 0.05% | – |
| LYRA | New | LYRA THERAPEUTICS INC | $59,000 | – | 5,218 | +100.0% | 0.02% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2021-05-05
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| FAT BRANDS INC | 12 | Q3 2023 | 0.6% |
| CHINOOK THERAPEUTICS INC | 11 | Q2 2023 | 8.9% |
| BELLUS HEALTH INC NEW | 10 | Q1 2023 | 4.7% |
| XTANT MED HLDGS INC | 10 | Q3 2023 | 5.1% |
| IVERIC BIO INC | 10 | Q1 2023 | 2.3% |
| MYRIAD GENETICS INC | 10 | Q1 2023 | 2.3% |
| HARBOR CUSTOM DEVELOPMENT IN | 10 | Q3 2023 | 0.1% |
| CRINETICS PHARMACEUTICALS IN | 9 | Q3 2023 | 4.1% |
| CTI BIOPHARMA CORP | 9 | Q1 2023 | 2.6% |
| POLISHED COM INC | 9 | Q2 2023 | 3.4% |
View Altium Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Marpai, Inc. | April 26, 2023 | 1,805,327 | 6.2% |
| Astria Therapeutics, Inc. | February 14, 2023 | 1,355,372 | 5.0% |
| HyreCar Inc. | February 14, 2023 | 1,688,120 | 5.6% |
| Muscle Maker, Inc. | February 14, 2023 | 2,888,085 | 5.0% |
| NeuroBo Pharmaceuticals, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| PALISADE BIO, INC.Sold out | February 14, 2023 | 0 | 0.0% |
| 1847 Goedeker Inc. | February 14, 2022 | 6,103,824 | 5.0% |
| BioRestorative Therapies, Inc. | February 14, 2022 | 200,000 | 5.0% |
| BriaCell Therapeutics Corp. | February 14, 2022 | 900,000 | 4.7% |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. | February 14, 2022 | 363,000 | 5.0% |
View Altium Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-02-21 |
| SC 13G | 2024-02-20 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
View Altium Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.